High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders

NCT06313502 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Plasma Cell Disorder

Interventions

DRUG: 75gm HDAA
DRUG: 100gm HDAA
DRUG: 125gm HDAA

Sponsor

University of Arkansas

Collaborators

[object Object]